Preview

Vertical Integration at Johnson & Johnson

Powerful Essays
Open Document
Open Document
1695 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Vertical Integration at Johnson & Johnson
Johnson & Johnson: Planning Vertical Integration
Team Synergy
April 4, 2011

In a competitive market to which Johnson and Johnson operates, the smallest of errors can lead to consequences which can cut revenue. When large mistakes occur, millions of dollars are lost, and even worse, there is a loss of customer confidence. Johnson and Johnson has had numerous recalls in their consumer healthcare division recently, which rocked the organization’s once sound image, and diminished its profits. These recalls have hurt Johnson and Johnson’s stocks and cost the company about $900 million in sales last year (Rockoff, 2011).
Opportunity
For Johnson and Johnson to continue being an industry leader, change is needed. An overhaul of the company’s production management must be examined. Recalls like ones they have been experiencing are unacceptable in the medical field. Mr. Weldon acknowledged customers were smarting from the recalls, and vowed to regain their trust and confidence once the recalled medicines return to the market at the end of this quarter (Rockoff, 2010). These recalls have led to the closing of plants, and loss of profits. Johnson and Johnson must reestablish itself as a premier, family oriented health care organization. Establishing consumer confidence once again and finding ways to regain its market share is the company’s primary strategic plan. An integration of the McNeil arm (which produces the products recalled) to the Johnson and Johnson production standards is needed. The recall problems have not been a one and done case. In the fiscal year of 2010 the FDA reported that Johnson and Johnson had to recall “approximately 288 million drug product units” (Perrone, 2011). Johnson and Johnson needs to find a way to control this problem before this arm of their corporation ruins its image which has been built over years. An integration of product management must be implemented with proper oversight, and execution. The ultimate goal is to minimize any



References: Adelman, M. A. (1955). Concept and Statistical Measurement of Vertical Integration. Retrieved April 3, 2011 from http://www.nber.org/chapters/c0965. Bigelow, L. (2010). Outsourcing May Lead to Failure in Tough Times and Even in Good. Retrieved April 3, 2011 from http://www.business.utah.edu/node/1198. Haase, S. (2002). Supply Chain Redesign: Advanced Sterilization Products (ASP). Retrieved April 3, 2011 from http://www.lda-us.com/Articles/AME_SupplyChainRedesign.pdf. MetricStream. (2011). Enhance Quality Tracking and Process Efficiency Optimization in Pharmaceutical Manufacturing. Retrieved April 3. 2011 from http://www.metricstream.com/whitepapers/html/pharma.htm. Perrone, M. (2011, March 29). Yahoo Finance. Retrieved April 2, 2011, from www.finance.yahoo.com. Rockoff, J. D. (2011, March). J&J Recall Watch: More Musty-smelling Tylenol Caplets. Retrieved April 2, 2011, from WSJ: www.wsj.com. Rockoff, J. D. (2010, August 19). WSJ. Retrieved April 3, 2011, from www.wsj.com.

You May Also Find These Documents Helpful

  • Good Essays

    Some medicines are beyond the scope of the FDA regulatory authority or some are approved to be used in other ways. Often some problems occur after the product has been approved by the FDA (Hooper, 2008). A manufacturer of the popular cholesterol reducing drug recalled 40 batches after finding out that it may contain small particles of glass. The glass particles were similar to the size of a grain of sand. If ingested it could be dangerous. There were no true adverse effects related to the recall are very low which means there are no injuries reported The pharmaceutical company Ranbaxy is recalling bottles of 10, 20, and 40 milligram tablets atorvastatin calcium, the generic version of Lipitor. The FDA granted the company approval of the manufacture of drug in New Jersey in 2011. Ranbaxy has been under the radar since 2006 for submitting false data to FDA and barred the company from manufacturing drugs in the United States until they met standards. Patients needed to find out if they pills they are taking are in the recall. All pharmacies recommend patients to check and see if their medicine is included in the recall before they take another dosage of their medicine. The patients do not have to do much as far as insurance purposes because they are automatically notified. If patient receives their medicine from the pharmacy they can swap out their pills there and mail order patients will…

    • 736 Words
    • 3 Pages
    Good Essays
  • Better Essays

    Johnson and Johnson

    • 1747 Words
    • 7 Pages

    The bad incident that Johnson& Johnson experienced is the Tylenol recall incident. Tylenol is one of the products of Johnson &Johnson. Tylenol is owned by McNeil Consumer Healthcare, a subsidiary of Johnson & Johnson. Tylenol is a medicine and it also can say is kind of drug. This “medicine” can find it at many places because it is a big market. The salers vending this good in several retail and wholesale outlet just like consumers can find it at any drug shop, any pharmacies and even the small shop or markets. After taking Tylenol, it can relieve suffering, reducing body temperature when fever, and remove the symptoms of…

    • 1747 Words
    • 7 Pages
    Better Essays
  • Better Essays

    Pharmacies have an enormous responsibility toward the community they serve because even a minor mistake can cause a big damage (temporal or permanent) on a patient’s…

    • 1706 Words
    • 7 Pages
    Better Essays
  • Powerful Essays

    Giant Foods Case Analysis

    • 1492 Words
    • 6 Pages

    This case involves convergent technologies, a blending of traditional and cutting-edge business models and an alliance between an established pharmaceutical provider and a fledgling, Information Technology based, Drug marketing firm. Together, these two companies endeavored to create a patient education and prescription drug compliance program by deploying the deep well of customer data acquired by Giant Foods and the proprietary software of Elensys Care services, Inc. Elensys uses information from Giants pharmacy to send personalized letters, written on pharmacy letterhead but often paid for by pharmaceutical companies, that remind customers to refill prescriptions and pitch new products to customers with particular ailments. Giant first tested the feasibility of running a drug compliance program in-house but quickly determined that its’ Information System requirements were too overwhelming and decided to outsource the program to Elensys.…

    • 1492 Words
    • 6 Pages
    Powerful Essays
  • Satisfactory Essays

    Chicago Tylenol Murders

    • 302 Words
    • 2 Pages

    The company began by going to the public and announcing for the consumers not to take the Extra Strength Tylenol and begin the recall all of the over the counter pain reliever,…

    • 302 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    Ethics Game Simulation

    • 791 Words
    • 4 Pages

    The first decision that had to be made was about a product already on the market that was contaminated yet only put a small percentage of users at a low risk. After narrowing the possibilities down to two solutions, the choice was made to warn customers of the potential dangers but to continue selling. Originally, this scenario had a familiar ring and the Ford Pinto case came into mind. (DeGeorge, 2005). Was our company about to do the same thing and knowingly put thousands of lives in jeopardy? Our initial decision had been to recall everything in order to avoid any chances of a lawsuit or accidental deaths. After several debates, though, it was determined that this was a different situation being that cars are luxuries and medicines were necessities. Since this particular product complied with FDA standards, no one saw any reason to pull it from the market.…

    • 791 Words
    • 4 Pages
    Good Essays
  • Good Essays

    In 1999 the Food and Drug Administration (FDA) had approved Vioxx, what would become Merck’s “blockbuster” drug. Although the FDA had approved the drug there was uncertainty of the safety of drug. Vioxx was approved to treat a variety of conditions, such as osteoarthritis and acute pain, but there was also a chance that it would increase cardiovascular problems. What I found most interesting about this case was the changes in how drugs are brought to consumers, from how they are approved to how they are informed of the drug.…

    • 553 Words
    • 3 Pages
    Good Essays
  • Satisfactory Essays

    Smells and discoloration were found on the wipes, with Burkholderia cepacia (B. cepacia), a bacterium that can be resistant to common antibiotics, discovered on some of the recalled products. B. cepacia can affect people with weakened immune systems or lung disease, causing pneumonia and other medical issues.…

    • 478 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    Tastee Essay

    • 737 Words
    • 3 Pages

    Johnson and Johnson thus requested products such as Benadryl, Motril, Rolaids, Simply Sleep, and Aspirins to be returned as a result of the discovery of safety issues that are dangerous to the consumer. I believe that this process of recall was one of…

    • 737 Words
    • 3 Pages
    Good Essays
  • Satisfactory Essays

    As the brand manager for OTC cold medicine group, my primary objective was to capitalize on marketing opportunities using Allstar’s identified strengths and weaknesses combined with the identified market threats and opportunities. Allstar’s singular product, Allround, is the market leader and the brand historically has had success in terms of profitability and sales. Allstar Brand’s single product line accounted for 40.4% of the cold product category of the market and 23.8% of the total OTC cold medicine market. However, Allstar management had, rightfully so, become concerned with the competitive nature of the OTC cold remedy market. Senior management suspected that competitive activity would lead to declining market share and profitability…

    • 198 Words
    • 1 Page
    Satisfactory Essays
  • Better Essays

    This report will seek to outline and discuss the challenges faced by Lorex Pharmaceuticals. This report will detail the circumstances that dictated the challenge faced Lorex Pharmaceuticals, as well as the key areas they must consider when attempting to resolve this challenge. The report will examine the possible outcomes, and make a final recommendation based on the information provided.…

    • 867 Words
    • 4 Pages
    Better Essays
  • Good Essays

    There are numerous ways of preventing medication errors; therefore, the Institute for Safe Medication Practices (ISMP) has recognized ten important factors that lead to errors. Anderson & Townsend, (2010) list them as: “patient information, drug information, adequate communication, drug packaging (labeling, nomenclature), medication storage (stock, standardization, and distribution), drug device acquisition (use and monitoring),…

    • 403 Words
    • 2 Pages
    Good Essays
  • Good Essays

    Never in the history of pharmaceutical marketing have the challenges been so intense and the stakes so high. Threats to growth and profitability have turned up the heat on pharmaceutical marketing teams to do more with less. As a…

    • 392 Words
    • 2 Pages
    Good Essays
  • Powerful Essays

    References: Carl, H. T., Lee-Ing Tong, & James, E. T. (2009). The vioxx recall case and comments. Competitiveness Review, 19(2), 114-118. doi: http://dx.doi.org/10.1108/10595420910942289…

    • 1377 Words
    • 6 Pages
    Powerful Essays
  • Satisfactory Essays

    One of the ways to overcome this setback is to replace the personnel who mad the decision to continue with the release of the product knowing the possible health risk and side effects.…

    • 360 Words
    • 2 Pages
    Satisfactory Essays